VE-4748

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVE-4748
Drug Alias Nameglaucoma therapy (Advanced Refractive Technologies/University of Arizona)monoclonal antibody therapy (Advanced Refractive Technology/University Arizona)monoclonal antibody therapy (University Arizona/Canadian Bio Med Systems/Ocular Therapeutics)VE-4748
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCadherin 5 modulators
TargetsCadherin 5
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Refractive TechnologiesCanadian Bio Med Systems IncOcular Therapeutics Inc +[4] 
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A